John NB schreef op 21 januari 2019 15:57:
Waarom zou Edison Investment Research Kiadis niet meer volgen?
Kiadis Pharma
Termination of coverage
Termination | Pharmaceuticals & healthcare | 10 Jan 2019
Edison Investment Research is terminating coverage on Kiadis Pharma (KDS). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
search.edisongroup.com/edisongroup/Ki...